|
IAC Express 2010 |
| Issue number 853: March 1, 2010 |
|
|
Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- ACIP
votes to recommend influenza vaccination for all people ages 6 months and
older
- ACIP
votes to recommend replacing Prevnar (7-valent pneumococcal conjugate
vaccine) with Prevnar 13 (13-valent pneumococcal conjugate vaccine); FDA
approves Prevnar 13
- WHO
recommends viruses for influenza vaccines for use in the 2010-11 northern
hemisphere influenza season
- IAC'S
Video of the Week features blogger moms discussing if the vaccine-autism
debate is over
- IAC
updates six translations of "When Do Children and Teens Need
Vaccinations?"
- IAC
updates its "Quiz #1: Immunization" and "Quiz #2: Vaccine Administration"
- Keep
vaccinating against seasonal and H1N1 influenza!
- CDC
offers health departments and coalitions lots of resources to plan for and
promote National Infant Immunization Week, scheduled for April 24-May 1
- "CDC
Features" educates parents about Hib disease and vaccine
- MMWR
publishes report about a case of presumptive abortive human rabies in
Texas in 2009
- PKIDS'
March 4 webinar will teach the basics of social marketing; March 11
webinar to focus on Skype and instant messaging
-
Reminder: NFID's Clinical Vaccinology Course is planned for March 12-14 in
San Diego
-
Phacilitate's European Vaccine Forum scheduled for June 21-23 in Barcelona
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 853: March 1, 2010 |
|
|
|
1. |
ACIP votes to recommend influenza vaccination for all people ages 6 months
and older
On February 24, CDC issued a press release
announcing that
ACIP has voted to recommend annual influenza vaccination for
all people ages 6 months and older. Portions of the press
release are reprinted below.
A panel of immunization experts voted today (February 24,
2010) to expand the recommendation for annual influenza
vaccination to include all people aged 6 months and older.
The expanded recommendation is to take effect in the 2010-2011 influenza season. The new recommendation seeks to
remove barriers to influenza immunization and signals the
importance of preventing influenza across the entire
population.
The Advisory Committee on Immunization Practices (ACIP),
which advises the Centers for Disease Control and Prevention
(CDC) on vaccine issues, voted on the new recommendation
during its February 24, 2010, meeting in Atlanta. The vote
took place against a backdrop of incremental increases in
the numbers and groups of people recommended for influenza
vaccination in years past, and lessons learned from the
world's still-ongoing first flu pandemic in 40 years.
Prior to today's vote, ACIP recommendations for seasonal
influenza vaccination--which focused on vaccination of
higher risk persons, children 6 months through 18 years of
age, and close contacts of higher risk persons--already
applied to about 85 percent of the U.S. population. . . .
To access the complete CDC press release, go to:
http://www.cdc.gov/media/pressrel/2010/r100224.htm
Back to top |
| |
|
|
2. |
ACIP votes to recommend replacing Prevnar (7-valent pneumococcal conjugate
vaccine) with Prevnar 13 (13-valent pneumococcal conjugate vaccine); FDA
approves Prevnar 13
On February 24, CDC's Advisory Committee on
Immunization
Practices (ACIP) voted to recommend replacing a 7-valent
pneumococcal conjugate vaccine (PCV; Prevnar) with a 13-valent PCV (Prevnar 13). Both vaccines are manufactured by
Wyeth, a wholly owned subsidiary of Pfizer.
Also on February 24, FDA approved Prevnar 13 for active
immunization to prevent invasive disease caused by
Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F,
9V, 14, 18C, 19A, 19F, and 23F. The vaccine is indicated for
use in children ages 6 months through 5 years in a four-dose
schedule at ages 2, 4, 6, and 12-15 months.
FDA issued a press release to announce the approval of
Prevnar 13; portions of it are reprinted below. Links to the
FDA press release, approval letter, and package insert are
given at the end of this IAC Express article.
The U.S. Food and Drug Administration today approved Prevnar
13, a pneumococcal 13-valent conjugate vaccine for infants
and young children ages 6 weeks through 5 years. Prevnar 13
will be the successor to Prevnar, the pneumococcal 7-valent
conjugate vaccine licensed by the FDA in 2000 to prevent
invasive pneumococcal disease (IPD) and otitis media. The
new vaccine extends the protection to six additional types
of the disease causing bacteria.
Prevnar 13 is approved for the prevention of invasive
disease caused by 13 different serotypes of the bacterium
Streptococcus pneumoniae. It also is approved for the
prevention of otitis media caused by the seven serotypes
shared with Prevnar. The bacterium can cause infections of
the blood, middle ear, and the covering of the brain and
spinal cord, as well as pneumonia. . . .
To access the complete FDA press release, click
here.
To access the approval letter, click
here.
To access the package insert, click
here.
Back to top |
| |
|
|
3. |
WHO recommends viruses for influenza vaccines for use in the 2010-11 northern
hemisphere influenza season
The World Health Organization (WHO) recently
announced the
viruses it recommends for use in the 2010-11 northern
hemisphere influenza season. The announcement is reprinted
below.
It is recommended that the following viruses be used for
influenza vaccines in the 2010-2011 influenza season
(northern hemisphere):
- An A/California/7/2009 (H1N1)-like virus;
- An A/Perth/16/2009 (H3N2)-like virus;**
- A B/Brisbane/60/2008-like virus.
** A/Wisconsin/15/2009 is an A/Perth/16/2009 (H3N2)-like
virus and is a 2010 southern hemisphere vaccine virus.
To access the WHO announcement, click
here.
Back to top |
| |
|
|
4. |
IAC'S Video of the Week features blogger moms discussing if the
vaccine-autism debate is over
Last month, The Lancet officially retracted its
publication
of Dr. Andrew Wakefield's 1998 study, which suggested a
possible link between MMR vaccine and autism. Mommy blogger
Daphne Brogdon gathers some of her fellow parenting bloggers
to discuss if the retraction signals that the vaccine-autism
debate is finally over. IAC's Video of the Week captures
their discussion. The video run time is 4 minutes.
The video will be available on the home page of IAC's
website through March 7. To access it, go to:
http://www.immunize.org and click on the image under the
words Video of the Week. It may take a few moments for the
video to begin playing; please be patient!
Remember to bookmark IAC's home page to view a new video
every Monday. To view an IAC Video of the Week from the
past, go to the video archive at http://www.immunize.org/votw
Back to top |
| |
|
|
5. |
IAC updates six translations of "When Do Children and Teens Need
Vaccinations?"
"When Do Children and Teens Need Vaccinations?"
is a handy
one-page chart for parents, illustrating all vaccines
recommended for children and teens ages 0-18 years. The
Arabic, Chinese, French, Korean, Russian, and Vietnamese
translations were recently revised to match the most recent
English version, which was updated in January to include
information about human papillomavirus (HPV) vaccination in
males. The Spanish version was previously updated; a link to
it is given below.
To access the Arabic version of the revised ready-to-print
(PDF) piece "When Do Children and Teens Need Vaccinations?"
go to: http://www.immunize.org/catg.d/p4050-20.pdf
To access the Chinese version of the revised ready-to-print
(PDF) piece "When Do Children and Teens Need Vaccinations?"
go to: http://www.immunize.org/catg.d/p4050-08.pdf
To access the French version of the revised ready-to-print
(PDF) piece "When Do Children and Teens Need Vaccinations?"
go to: http://www.immunize.org/catg.d/p4050-10.pdf
To access the Korean version of the revised ready-to-print
(PDF) piece "When Do Children and Teens Need Vaccinations?"
go to: http://www.immunize.org/catg.d/p4050-09.pdf
To access the Russian version of the revised ready-to-print
(PDF) piece "When Do Children and Teens Need Vaccinations?"
go to: http://www.immunize.org/catg.d/p4050-07.pdf
To access the Vietnamese version of the revised ready-to-print (PDF) piece "When Do Children and Teens Need
Vaccinations?" go to:
http://www.immunize.org/catg.d/p4050-05.pdf
To access the Spanish version the revised ready-to-print
(PDF) piece "When Do Children and Teens Need Vaccinations?"
go to: http://www.immunize.org/catg.d/p4050-01.pdf
To access the English version of the revised ready-to-print
(PDF) piece "When Do Children and Teens Need Vaccinations?"
go to: http://www.immunize.org/catg.d/p4050.pdf
IAC's Print Materials web section offers healthcare
professionals and the public approximately 250 FREE English-language materials (many also available in translation),
which we encourage website users to print out, copy, and
distribute widely. To access all of IAC's free print
materials, go to: http://www.immunize.org/printmaterials
Back to top |
| |
|
|
6. |
IAC updates its "Quiz #1: Immunization" and "Quiz #2: Vaccine Administration"
IAC recently revised its two quizzes for
healthcare
professionals: "Quiz #1: Immunization" and "Quiz #2: Vaccine
Administration." To test your knowledge of immunization and
vaccine administration, just click on the links below:
To access the revised ready-to-print (PDF) version of "Quiz
#1: Immunization," go to:
http://www.immunize.org/catg.d/p7001.pdf
To access the revised ready-to-print (PDF) version of "Quiz
#2: Vaccine Administration," go to:
http://www.immunize.org/catg.d/p7002.pdf
IAC's Print Materials web section offers healthcare
professionals and the public approximately 250 FREE English-language materials (many also available in translation),
which we encourage website users to print out, copy, and
distribute widely. To access all of IAC's free print
materials, go to: http://www.immunize.org/printmaterials
Back to top |
| |
|
|
7. |
Keep vaccinating against seasonal and H1N1 influenza!
Please continue to vaccinate patients against
seasonal and
H1N1 influenza. Remember: 2009 H1N1 influenza vaccine will
not protect people against seasonal influenza, and seasonal
influenza vaccine will not protect against H1N1 influenza.
Providers who don't have seasonal influenza vaccine or H1N1
influenza vaccine can direct patients to the Google Flu Shot
Finder at http://www.google.com/flushot
Back to top |
| |
|
|
8. |
CDC
offers health departments and coalitions lots of resources to plan for and
promote National Infant Immunization Week, scheduled for April 24-May 1
National Infant Immunization Week (NIIW) is an
annual
observance to highlight the importance of protecting infants
from vaccine-preventable diseases. It is a call to action
for parents, caregivers, and healthcare providers to ensure
that infants are fully immunized. This year NIIW will be
held April 24-May 1 and will coincide with Vaccination Week
in the Americas.
Any health department or immunization coalition interested
in promoting infant immunization within their community will
find abundant useful information on the CDC's NIIW website.
Resources include tools for planning events and promoting
them through the media; listings of NIIW activities and
events planned across the nation; and educational materials
for providers and parents.
To access NIIW resources, go to:
http://www.cdc.gov/vaccines/events/niiw
Back to top |
| |
|
|
9. |
"CDC
Features" educates parents about Hib disease and vaccine
The "CDC Features" web section includes
information for
parents about Hib disease. "Is Your Child Protected against
Hib Disease?" teaches parents about the disease, its
seriousness, and the vaccine that protects against it. It
also informs healthcare providers that the Hib vaccines
currently available are ActHIB, Hiberix, PedvaxHIB, and
Pentacel.
To access "Is Your Child Protected against Hib Disease? go
to:
http://www.cdc.gov/Features/HibDisease
To access the recently updated provider resource "Q&A for
Providers about the Hib Vaccination Schedule," go to:
http://www.cdc.gov/vaccines/vpd-vac/hib/faqs-hcp.htm
To access an alphabetical index of all "CDC Features," go
to:
http://www.cdc.gov/az/a.html
Back to top |
| |
|
|
10. |
MMWR publishes report about a case of presumptive abortive human rabies in
Texas in 2009
CDC published "Presumptive Abortive Human
Rabies--Texas,
2009" in the February 26 issue of MMWR. The first paragraph
is reprinted below.
Rabies is a serious zoonotic disease. Recovery has been well
documented in only six human patients worldwide. Five of
those patients had received rabies vaccinations before
illness; one had not received rabies vaccination but
survived infection after prolonged intensive care. In most
of these survivors, moderate to profound neurologic sequelae
occurred. In all six survivors, rabies was diagnosed based
on exposure history, compatible clinical symptoms, and
detection of rabies virus-neutralizing antibodies (VNA).
This report describes the clinical course and laboratory
findings of an adolescent girl with encephalitis who had not
had rabies vaccination and who had been exposed to bats 2
months before illness. Antibodies to rabies virus were
detected in specimens of the girl's serum and cerebrospinal
fluid (CSF) by indirect fluorescent antibody test (IFA).
However, the presence of rabies VNA was not detected until
after she had received single doses of rabies vaccine and
human rabies immune globulin (HRIG). Although the patient
required multiple hospitalizations and follow-up visits for
recurrent neurologic symptoms, she survived without
intensive care. No alternate etiology was determined, and
abortive human rabies (defined in this report as recovery
from rabies without intensive care) was diagnosed. Public
education should emphasize avoiding exposure to bats and
other potentially rabid wildlife and seeking prompt medical
attention after exposure to such animals. Rabies is
preventable if rabies immune globulin and vaccine are
administered soon after an exposure; however, this case also
suggests the rare possibility that abortive rabies can occur
in humans and might go unrecognized.
To access the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5907a1.htm
Back to top |
| |
|
|
11. |
PKIDS' March 4 webinar will teach the basics of social marketing; March 11
webinar to focus on Skype and instant messaging
PKIDS (Parents of Kids with Infectious Diseases)
has
scheduled a one-hour webinar for March 4. It will provide
hands-on, how-to instruction on various aspects of creating
a social marketing (NOT "social media") campaign. A March 11
webinar will focus on Skype and instant messaging. The
webinars are part of Communications Made Easy, a PKIDS'
program intended to help immunization educators learn the
ropes of social marketing and traditional and social media.
SOCIAL MARKETING 101 is scheduled for March 4 at 9AM Pacific
Time. Space is limited and pre-registration is recommended.
To register, go to:
https://cc.readytalk.com/cc/schedule/display.do?udc=3u1dbkcpspzz
SKYPE/INSTANT MESSAGING is scheduled for March 11 at 1PM
Pacific Time. Space is limited and pre-registration is
recommended. To register, go to:
https://cc.readytalk.com/cc/schedule/display.do?udc=s0i6x365tqag
For more information on the Communications Made Easy
program, go to: http://www.pkids.org/cme
PKIDS supports people whose children have been affected by
viral hepatitis, HIV/AIDS, and other chronic, viral
infectious diseases, and educates the public about effective
disease prevention practices. To visit the PKIDS website, go
to: http://www.pkids.org
Back to top |
| |
|
|
12. |
Reminder: NFID's Clinical Vaccinology Course is planned for March 12-14 in
San Diego
The National Foundation for Infectious Diseases
will hold
its Clinical Vaccinology Course in San Diego on March 12-14.
This course focuses on new developments and issues related
to the use of vaccines. Continuing education (CE) credit is
available for physicians, nurses, and pharmacists.
To access comprehensive course information, including the
course outline and available CE credit, go to:
http://www.nfid.org/pdf/conferences/course310.pdf
To register online, go to:
https://secure.bnt.com/webresponse/nfid/course310
Back to top |
| |
|
|
13. |
Phacilitate's European Vaccine Forum scheduled for June 21-23 in Barcelona
Phacilitate, a life-sciences event planning
company, has
scheduled its European Vaccine Forum for June 21-23 in
Barcelona. As in the past, the company's Active
Immunotherapeutics Forum will run concurrently with the
Vaccine Forum.
For comprehensive information on both forums, go to:
http://www.phacilitate.co.uk/pages/barcelona
Back to top |
| |
|
|
